Chronic pain clinical trials in Pointe-Claire, Quebec
Part of chronic pain trials in Quebec.
4
Trials
0
Recruiting or not yet
4
Trial sites
Trials with a site in Pointe-Claire
4 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis NCT02159053 | Completed | Phase 3 | Novartis Pharmaceuticals | 2015-05-18 |
| 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis NCT01649375 | Completed | Phase 3 | Novartis Pharmaceuticals | 2012-10-18 |
| An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain NCT00487435 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06 |
| A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain NCT00361504 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11 |
Facilities listed in the registry
- Novartis Investigative Site (2 trial sites)
Facility names are as entered by study registrants. This is not a clinic directory.
Map
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.